Home / Stocks / Krsnaa Diagnostics Ltd
KRSNAA

Krsnaa Diagnostics Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹515.65

Change

+4.35 (0.85%)

Open

₹511.3

Prev. Close

₹511.3

Day High

₹530.0

Day Low

₹509.45

Volume Analysis

Traded

21,290

Delivered

9,191

Delivery %

43.17%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Strong operating margin (26.0%)

Weaknesses (0)

No signal for this stock

Opportunities (2)

  • •Strong 3-year EPS growth (16.5%)
  • •Strong 3-year revenue growth (16.7%)

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹547.84 ₹538.92 ₹527.29 ₹518.37 ₹506.74 ₹497.82 ₹486.19
Fibonacci ₹538.92 ₹531.07 ₹526.22 ₹518.37 ₹510.52 ₹505.67 ₹497.82
Camarilla ₹521.3 ₹519.42 ₹517.53 ₹518.37 ₹513.77 ₹511.88 ₹510.0

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-30.36%

1 Week

-0.46%

1 Month

+0.13%

3 Months

-8.19%

6 Months

-8.34%

1 Year

-36.96%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹474.49

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

8.2%

Net margin 11.14% × asset turnover 0.37x × equity multiplier 1.99x

Company Overview

Sector

Healthcare

Market Cap

₹1,661 Cr

P/E (TTM)

16.9

ROE

10.9%

Book Value

₹320.0

Face Value

₹5.0

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Krsnaa Diagnostics Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 57/100. The strongest factor is Growth (88/100), while Momentum (13/100) is the weakest area to weigh before deciding. Notably: Strong operating margin (26.0%). Strong 3-year EPS growth (16.5%).

TopFund Score — Fundamentals Quality

57/100 — Average

Data confidence: 79/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

84

Growth

88

Valuation

61

Cash Flow

45

Corporate Governance

45

Momentum

13

Institutional Ownership

33

Business Quality

70

Risk & Volatility

50

Liquidity

24

From Screener.in

  • −Promoter holding is low: 27.1%
  • −Company has a low return on equity of 9.11% over last 3 years.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Earnings Call Transcript for quarter and half year ended September 30, 2026

KFin Technologies shifts corporate office from December 1, 2026; registered office remains unchanged.

Audio recording of Q2FY27 earnings call dated November 03, 2026 uploaded on company website.

Krsnaa Diagnostics wins Delhi MCD 10-year cash PPP project for CT Scan and MRI at three hospitals.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 155 158 166 170 186 175 186 193 206 181 193 236 271
Expenses + 124 121 123 128 137 129 133 142 147 135 138 178 200
Operating Profit 32 37 44 43 49 45 53 51 59 46 55 58 71
OPM % 20.0% 24.0% 26.0% 25.0% 27.0% 26.0% 28.0% 27.0% 29.0% 26.0% 28.0% 25.0% 26.0%
Other Income + 4 4 4 7 5 9 4 4 4 4 32 7 6
Interest 3 4 7 5 6 6 7 6 8 8 12 15 15
Depreciation 19 21 18 21 22 23 22 22 24 23 23 28 29
Profit before tax 13 16 23 23 25 25 29 27 32 20 52 22 33
Tax % 22.0% 19.0% 17.0% 23.0% 23.0% 24.0% 28.0% 25.0% 24.0% 23.0% 19.0% 26.0% 25.0%
Net Profit + 10 13 19 18 20 19 21 21 24 15 42 17 25
EPS in Rs 3 4 6 6 6 6 6 6 7 5 13 5 8
Raw PDF — — — — — — — — — — — — —
YoY Sales growth 26 34 25 22 20 10 12 13 11 4 4 22 32

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 39 61 455 487 620 717 773 880
Expenses + 30 42 324 365 475 527 561 650
Operating Profit 9 19 132 122 144 190 212 230
OPM % 23.0% 31.0% 29.0% 25.0% 23.0% 27.0% 27.0% 26.0%
Other Income + 3 2 15 19 17 26 43 49
Interest 9 9 18 8 16 25 34 50
Depreciation 6 12 41 54 75 88 90 102
Profit before tax -3 0 87 80 70 103 130 127
Tax % 49.0% 180.0% 21.0% 23.0% 19.0% 24.0% 22.0% —
Net Profit + -5 0 68 62 57 78 101 98
EPS in Rs -2 0 22 20 18 24 31 30
Dividend Payout % 0.0% 0.0% 11.0% 14.0% 14.0% 11.0% 6.0% —
Sales growth — 56 — 7 27 16 8 16

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 6 6 669 723 794 867 964 1,022
Borrowings + 131 102 41 32 160 204 534 596
Other Liabilities + 44 80 150 137 201 192 304 429
Total Liabilities 186 192 875 908 1,170 1,278 1,819 2,064
Fixed Assets + 74 131 386 471 647 670 656 870
CWIP 20 6 28 25 10 3 208 5
Investments 1 1 0 0 0 32 57 57
Other Assets + 91 55 461 412 513 573 897 1,131
Total Assets 186 192 875 908 1,170 1,278 1,819 2,064
Equity Capital 5 5 16 16 16 16 16 16

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2016 Mar 2017 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + -23 64 128 76 24 87 143
Cash from Investing Activity + -47 -54 -241 -109 -129 -100 -396
Cash from Financing Activity + 105 -41 176 -33 84 14 279
Net Cash Flow 36 -31 64 -66 -20 1 26
Free Cash Flow -69 10 -3 -58 -169 -24 -72
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit -254 344 103 73 30 56 81

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 27.03% → 27.11%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 52.94% 54.27% 54.23% 53.34% 54.27% 54.94% 55.25% 54.27% 54.86% 55.09% 54.08% 54.55%
Promoters 27.03% 27.03% 27.17% 27.17% 27.24% 27.24% 27.11% 27.11% 27.11% 27.11% 27.11% 27.11%
FII 3.44% 3.34% 3.33% 3.63% 4.04% 3.55% 3.4% 3.66% 4.17% 3.91% 4.28% 3.84%
DII 16.59% 15.37% 15.26% 15.86% 14.46% 14.26% 14.24% 14.96% 13.85% 13.89% 14.51% 14.5%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Krsnaa Diagnostics Ltd (this stock) 1,661 16.9 1.6 10.9%
Tarsons Products Limited 1,678 205.0 2.65 2.44%
Fischer Medical Venture L 1,642 144.0 3.52 8.91%
Suraksha Diagnostic Ltd 1,780 42.6 6.45 14.2%
Ngl Fine Chem Limited 1,783 27.9 4.92 17.4%
Bharat Parenterals Ltd. 1,522 1227.0 4.59 -2.54%
Amrutajan Health Ltd 1,461 71.7 13.58 20.0%

Which Mutual Funds Hold Krsnaa Diagnostics Ltd?

Frequently Asked Questions about Krsnaa Diagnostics Ltd

Community Sentiment

What are other investors saying about Krsnaa Diagnostics Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.